These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2877149)

  • 21. Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study.
    Tacconelli E; Tumbarello M; Donati KG; Bettio M; Spanu T; Leone F; Sechi LA; Zanetti S; Fadda G; Cauda R
    Clin Infect Dis; 2001 Nov; 33(10):1628-35. PubMed ID: 11595984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection.
    Aubert G; Passot S; Lucht F; Dorche G
    J Antimicrob Chemother; 1990 Mar; 25(3):491-3. PubMed ID: 2140112
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro activity of oxacillin, vancomycin and teicoplanin against staphylococci isolated from patients on surgical and coronary intensive care units.
    Kucukates E; Nalan Karayel E; Gultekin N; Okuyan E; Kansiz E; Gurler N
    Int J Antimicrob Agents; 2004 Aug; 24(2):193-4. PubMed ID: 15288323
    [No Abstract]   [Full Text] [Related]  

  • 24. Occurrence and mechanisms of glycopeptide resistance in gram-positive cocci.
    Saha V; Gupta S; Daum RS
    Infect Agents Dis; 1992 Dec; 1(6):310-8. PubMed ID: 1344669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)].
    Kayaokay Y; Hasçelik G; Gür D; Akalin E
    Mikrobiyol Bul; 1991 Oct; 25(4):321-5. PubMed ID: 1839050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teicoplanin in the treatment of infections caused by coagulase-negative staphylococci.
    Harding I; Garaud JJ
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():93-103. PubMed ID: 2965137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of coagulase-negative staphylococci to transfer antibiotic resistance to Staphylococcus aureus 1030 in mixed cultures.
    Fawcett CJ; Lord VL; Lacey RW
    J Gen Microbiol; 1981 Oct; 126(2):507-9. PubMed ID: 7338731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Teicoplanin-resistant coagulase-negative staphylococcus.
    Grant AC; Lacey RW; Brownjohn AM; Turney JH
    Lancet; 1986 Nov; 2(8516):1166-7. PubMed ID: 2877317
    [No Abstract]   [Full Text] [Related]  

  • 29. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
    Thamlikitkul V
    J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Epsilometer test (E test) for testing the susceptibility of coagulase-negative staphylococci to teicoplanin.
    Martin E; Nouvellon M; Pestel M; Pons JL; Lemeland JF
    J Antimicrob Chemother; 1995 Jul; 36(1):83-91. PubMed ID: 8537287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-level teicoplanin resistance and heteroresistance to vancomycin.
    Sieradzki K; Villari P; Tomasz A
    Ann Intern Med; 1998 Feb; 128(3):245. PubMed ID: 9454540
    [No Abstract]   [Full Text] [Related]  

  • 32. Susceptibility of gram positive cocci to teicoplanin. Three year survey (1984-1986) at Perugia University.
    Pasticci MB; Baldelli F; Moretti A; Menichetti F; Pauluzzi S
    Boll Ist Sieroter Milan; 1989; 68(1):5-6. PubMed ID: 2535245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the in-vitro activity of the glycopeptide antibiotic LY333328 in comparison with vancomycin and teicoplanin.
    Harland S; Tebbs SE; Elliott TS
    J Antimicrob Chemother; 1998 Feb; 41(2):273-6. PubMed ID: 9533471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial activity of daptomycin in comparison to glycopeptides and other antimicrobials when tested against numerous species of coagulase-negative Staphylococcus.
    Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):212-4. PubMed ID: 22608137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lytic action of lysostaphin on susceptible and resistant strains of Staphylococcus aureus.
    Zygmunt WA; Browder HP; Tavormina PA
    Can J Microbiol; 1967 Jul; 13(7):845-53. PubMed ID: 6036889
    [No Abstract]   [Full Text] [Related]  

  • 36. The bactericidal activity of vancomycin and teicoplanin against methicillin-resistant strains of coagulase negative Staphylococcus spp.
    O'Hare MD; Felmingham D; Grüneberg RN
    J Antimicrob Chemother; 1989 May; 23(5):800-2. PubMed ID: 2527220
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antibiotic resistance of coagulase-positive staphylococci isolated from patients in the Katowice province in the years 1962-1967].
    Szaflarski J; Rogala D; Urbańska L; Rozanowicz A; Holowiecka D; Kapp Z
    Przegl Epidemiol; 1971; 25(1):91-5. PubMed ID: 4932592
    [No Abstract]   [Full Text] [Related]  

  • 38. Activity of telavancin compared to other agents against coagulase-negative staphylococci with different resistotypes by time kill.
    Lin G; Pankuch GA; Appelbaum PC; Kosowska-Shick K
    Diagn Microbiol Infect Dis; 2012 Jul; 73(3):287-9. PubMed ID: 22575272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro susceptibility of Staphylococci and Enterococci to vancomycin and teicoplanin.
    Guzek A; Korzeniewski K; Nitsch-Osuch A; Rybicki Z; Prokop E
    Adv Exp Med Biol; 2013; 788():125-32. PubMed ID: 23835969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sensitivity to vancomycin and teicoplanin of coagulase-negative staphylococci isolated from clinical specimens].
    Młynarczyk G; Młynarczyk A; Luczak M; Jeljaszewicz J
    Med Dosw Mikrobiol; 1999; 51(1-2):17-23. PubMed ID: 10865426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.